Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 30, 1999

View Archived Issues

Connetics expands dermatology pipeline

Gene mutation identified as cause of Papillon-Lefevre syndrome

Vitex receives milestone investment for progress with Inactine

Biopure expands phase III Hemopure clinical trial into Canada

GelTex and Sankyo finalize agreements for CholestaGel and second-generation product

Elan confirms arrangements for purchase of Axogen

AxyS Advanced Technologies and Cephalon to collaborate in combinatorial chemistry

Schwarz, ARYx team up to design novel antiarrhythmic drugs

Reboxetine + pindolol rapidly relieves symptoms of depression and other CNS disorders

FDA approves new treatment for respiratory failure in neonates

AstraZeneca seeks approval of Atacand HCT in the U.S.

Schwarz obtains expanded rights to develop and market antiparkinsonian patch

Potent, nonpeptide angiotensin II receptor antagonists discovered at Chinese university

Japanese approval obtained for Relenza

Byk Gulden compounds exhibit potent anti-H. pylori activity

Benzofurans with cardioprotective, anxiolytic activity designed at Egis

International patent covers AHP's new antidiabetic agents

Japanese labs discover new imidazoles useful for liver disease

Warner-Lambert reports R&D progress in the area of kinase inhibitors

Altropane detects abnormal increases in brain DATs in patients with longstanding ADHD

Crinone associated with reduced implantation, pregnancy rates following IVF-ET

Elan seeks U.S. approval for ziconotide

Boston Life Sciences to meet with FDA regarding Therafectin

Expanded patent protection for Theratechnologies' GRF analogue program

Irbesartan and other selective AT1 receptor antagonists may offer new approach to stroke management

FDA approves Ligand's Targretin Capsules for treatment of CTCL

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...